Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors

This publication has 32 references indexed in Scilit:

• Hematopoietin sub-family classification based on size, gene organization and sequence homology
  Current Biology, 1993
• Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system
  Immunology Today, 1993
• Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes
  Brain, Behavior, and Immunity, 1992
• Interleukin‐4 differentially regulates interleukin‐2‐mediated and CD2‐mediated induction of human lymphokine‐activated killer effectors
  European Journal of Immunology, 1992
• Expression of prolactin and its receptor in human lymphoid cells
  Molecular Endocrinology, 1992
• Effect of Prolactin on Human Natural Killer Activity
  Annals of the New York Academy of Sciences, 1990
• A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain
  Biochemical and Biophysical Research Communications, 1989
• Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.
  The Journal of Experimental Medicine, 1988
• Suppression of Macrophage Activation and T-Lymphocyte Function in Hypoprolactinemic Mice
  Science, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987